p. 106−111
2717-0721
Vol.13/No.4
p. 112−117
2717-0721
Vol.13/No.4
0.05). According to the type of recurrence, there was a significant difference between the two groups; in group A, the first recurrence was major in 33% of the patients while in group B, this rate was about 28.8% (P<0.05).Conclusion: According to the present study, initial therapeutic dosage did not influence the recurrence rate although the type of recurrence was influenced. Patients treated with higher initial steroid dosages experienced their first episode as a minor recurrence while patients treated with lower initial steroid dosages experienced major recurrences with a higher probability as their first episode.]]>
p. 118−121
2717-0721
Vol.13/No.4
p. 122−127
2717-0721
Vol.13/No.4
p. 128−130
2717-0721
Vol.13/No.4
0.05). There were no therapeutic adverse effects in the groups. There was a statistically significant difference in all measured scores between two groups in the first and second follow-up sessions (P < 0.0001). Conclusion: Malva Sylvestris seems to be a safe and effective therapeutic modality for the treatment of hand eczema and can be used as an optimal substitute for corticosteroids and antihistamines.]]>
p. 131−134
2717-0721
Vol.13/No.4
p. 135−138
2717-0721
Vol.13/No.4
p. 139−141
2717-0721
Vol.13/No.4
p. 142−143
2717-0721
Vol.13/No.4
p. 144−145
2717-0721
Vol.13/No.4